Notícias/Reuters/Curevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechCurevac and GSK agree to resolve patent dispute litigation with Pfizer and BioNTechRefinitivMenos de 1 minuto de leituraCVACGSKPFEBNTXCurevac CVAC said on Thursday that the company and GSK GSK have entered an agreement to resolve patent dispute with Pfizer PFE and BioNTech BNTX over mRNA-based COVID-19 vaccines. Ações AlemãsAções EUAAções InglesasDemonstrações financeirasEuropaReuters© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlMostrar MaisEntrar ou criar uma conta gratuita para ler essa notíciaVamos lá
